AB21® clinical trial results, presented at IHMC

Jordi Espadaler Mazo, PhD, talks in the latest International Human Microbiome Consortium (IHMC 2021) about latest discoveries on probiotics and COVID-19. A randomized, controlled trial with the probiotic formula AB21® is presented.